Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.49 | N/A |
| PEG Ratio (TTM) | -1.47 | N/A |
| P/S Ratio (TTM) | 0.29 | N/A |
| P/B Ratio (TTM) | 1.43 | N/A |
| P/FCF Ratio (TTM) | 14.06 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.92 | N/A |
| Price to 5YR AVG FCF Ratio | 8.78 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.51% | N/A |
| ROE (TTM) | 10.75% | N/A |
| Net Profit Margin (TTM) | 2.16% | N/A |
| ROIC 5YR AVG | 13.59% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 94.21% | 51.54% | 37.25% |
| Revenue | 3.76% | 13.91% | 18.91% |
| Net Income | 91.60% | 52.33% | 40.95% |
| Cash Flow | 295.79% | 1,176.08% | 686.61% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.20 | N/A |
| Quick Ratio (TTM) | 0.41 | N/A |
| D/E Ratio (TTM) | 1.45 | N/A |
| Interest Coverage (TTM) | 3.89 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.77 | N/A |
| LTL to 5YR AVG FCF | 6.13 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.00% | N/A |